Berkeley Fermentation Science Inc.

OAKLAND, CA · Biotech · Private

Engineered probiotic yeast (S. boulardii) that biosynthesize sulforaphane in the human gastrointestinal tract

Claim this profile

Follows are private to you and power your alerts

Updated · berkeleyfermentationscience.com

Sector
Biotech
Headquarters
OAKLAND, CA
Latest Form D
$10.5M, May 2023
Total capital
$12.4M
Federal grants
$1.9M
4 awards · 2018–2021
Rank in peer group#85 of 326
Private capital raised
$10.5M
1 Form D · last May 2023
42 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
14 pending · first 2025
Rank in peer group#80 of 326

Capital timeline

201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $12.4M$1.4M$325K$52K$100K1st Form D$10.5M
201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $12.4M$1.4M$325K$52K$100K1st Form D$10.5M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$10.5M
  • Federal grantAgriculture · Engineering Saccharomyces Cerevisiae For Increased Biotransformation And Production Of Tropical Flavors From Agricultural Products$100K
  • Federal grantHealth and Human S · Phase I · Engineering probiotic yeast for efficient sulforaphane delivery$52K
  • Federal grantHealth and Human S · Phase I · Engineering probiotic yeast for efficient sulforaphane delivery$325K
  • Federal grantNSF · Phase II · SBIR Phase II: Engineering brewer's yeast for enhanced flavor production during fermentation$1.4M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

57months

from Berkeley Fermentation Science Inc.’s first federal award to its first private round.

First federal award · Aug 2018
NSF · $1.4M
First Form D · May 2023
$10.5M · 1st Form D
Awards before first raise
4 awards

An association in public records, not a cause or a prediction.

Standing among 326 peers

Line = median

Biotech · Molecule

  • Federal grants#85 · top 26%
  • Granted patents#80 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Charles DenbyResearcherExecutive Officer, DirectorLinked by $1.8M in grants as PI
  • Philip AustinDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 15
  • GrantedGenetically Engineered Yeast Cells And Methods Of Use ThereofUSPTOUS 12,503,675
  • PendingGenetically Engineered Yeast Cells And Methods Of Use ThereofUSPTOApplication 18957310
  • PendingMethods And Compositions For Reducing Smoke Taint In Fermented BeveragesUSPTOApplication 18699011
Show all 15 patent records
  • Genetically Engineered Yeast Cells And Methods Of Use ThereofDec 23, 2025 · US 12,503,675Granted
  • Genetically Engineered Yeast Cells And Methods Of Use ThereofJun 12, 2025 · Application 18957310Pending
  • Methods And Compositions For Reducing Smoke Taint In Fermented BeveragesDec 12, 2024 · Application 18699011Pending
  • Methods And Compositions For Gamma-decalactone Biosynthesis In Fermented BeveragesDec 5, 2024 · Application 18560836Pending
  • Genetically Engineered Yeast Cells And Methods Of Use ThereofDec 21, 2023 · Application 18036472Pending
  • Methods And Compositions For Gamma-decalactone Biosynthesis In Fermented BeveragesApplication PCTUS2022030364Pending
  • Genetically Engineered Yeast Cells And Methods Of Use ThereofApplication PCTUS2021059201Pending
  • Methods And Compositions For Reducing Smoke Taint In Fermented BeveragesApplication 63254042Pending
  • Methods And Compositions For Gamma-decalactone Biosynthesis In Fermented BeveragesApplication 63190954Pending
  • Genetically Engineered Yeast Cells And Methods Of Use ThereofApplication PCTUS2024061971Pending
  • Genetically Modified Yeast For Production Of Non-alcoholic BeveragesApplication 19514475Pending
  • Genetically Modified Yeast For Production Of Non-alcoholic BeveragesApplication PCTUS2024044299Pending
  • Genetically Engineered Yeast Cells And Methods Of Use ThereofApplication 63614871Pending
  • Genetically Modified Yeast For Production Of Non-alcoholic BeveragesApplication 63579269Pending
  • Methods And Compositions For Reducing Smoke Taint In Fermented BeveragesApplication PCTUS2022077806Pending
  • Daedalus Systems Inc./deSimilar federal contract value in Biotech · null in contracts
  • Medium CorpSimilar federal contract value in Biotech · null in contracts
  • Serotiny, Inc.Similar federal contract value in Biotech · null in contracts
  • BACTANA CORP.Similar federal contract value in Biotech · null in contracts
  • NOVOME BIOTECHNOLOGIES, INC.Similar federal contract value in Biotech · null in contracts
  • Ichor Biologics LLCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .